NF-kappa-B inhibitor beta (NFKBIB) Peptide
NFKBIB
Reactivity: Human
CP
Sodium azide
-
- Target See all NFKBIB products
- NFKBIB (NF-kappa-B inhibitor beta (NFKBIB))
- Peptide Type
- Recombinant
- Origin
- Human
- Application
- Control Peptide (CP)
- Characteristics
- Concentration Definition: by dry weight
- Sterility
- Sterile filtered
-
-
- Application Notes
- Control peptide should be used at 1.0 µg per 1.0 µl of antiserum in per assay.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1.0 mg/mL
- Preservative
- Sodium azide
- Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- -20 °C
-
- Target
- NFKBIB (NF-kappa-B inhibitor beta (NFKBIB))
- Synonyms
- NFKBIB Peptide, IKB-beta Peptide, IKappaBbeta Peptide, IkB Peptide, IkBb Peptide, IKBB Peptide, TRIP9 Peptide, NFKB inhibitor beta Peptide, nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, beta Peptide, NFKBIB Peptide, Nfkbib Peptide
- Background
- Synonyms: NF-kappa-B inhibitor beta antibody, NF-kappa-BIB, I-kappa-B-beta, Thyroid receptor-interacting protein 9, TRIP-9, IkB-B
-
You are here:
